Latest news in cancer
Peripheral T-cell lymphoma faces challenges
The Cleveland Clinic of the United States Eric D. His et al. Reported that the diagnosis of peripheral T cell lymphoma (PTCL) in the United States varies...
AstraZeneca targeted drug Acalabrutinib has a new way to treat chronic lymphocytic leukemia
Acalabrutinib is a second-generation tyrosine kinase (BTK) inhibitor, a newer drug that can improve the survival of chronic lymphocytic leukemia (CLL) and...
Pathogenesis and treatment of mature T cell tumors
Mature T-cell tumors, such as non-Hodgkin T-cell lymphoma, are highly invasive and drug-resistant, and patients often have a poor prognosis. Recently,...
Can obesity cause cancer?
Obesity not only runs counter to the aesthetics of people, but also causes many chronic diseases. Some studies have shown that body mass index (BMI) is related...
Guideline for the treatment of mixed phenotype acute leukemia
A study conducted at the Los Angeles Children ’s Hospital is providing the best treatment for a rare invasive leukemia called mixed phenotype acute leukemia...
Treatment for advanced lymphoma
Yesterday, the US FDA announced the approval of Seattle Genetics’ antibody-drug conjugate Adcetris (brentuximab vedotin) in combination with chemotherapy...
This anticancer drug still benefits after 5 years of treatment for leukemia
According to the results of a 5-year follow-up of the key PACE trial published in the Journal of Hematology, panatinib (Ponatinib, Iclusig) has maintained...
Drugs for lymphoma leukemia to treat brain tumors
New Cleveland Clinic research shows for the first time that FDA-approved ibrutinib (ibrutinib) for lymphoma and leukemia may also help treat the most common...
First-line bosutinib is superior to imatinib in the treatment of leukemia
Bosutinib is a Src / Abl dual tyrosine kinase inhibitor approved for the treatment of newly diagnosed chronic phase (CP) chronic myelogenous leukemia (CML), or...
Lipid-lowering drugs are expected to assist in the treatment of leukemia
The latest research found that some statins can improve the efficacy of chemotherapy drugs used to treat blood cancer in mouse models. Statins are drugs that...
Can bone marrow fibrosis drugs induce lymphoma?
Bone marrow fibrosis is a rare chronic disease of bone marrow hematopoietic cells. They benefit from JAK2 inhibitor drugs: symptom relief, prolonged survival,...
Venetoclax therapy for leukemia
On June 8 , the US FDA approved Venetoclax ( VENCLEXTA , AbbVie Inc. and Genentech Inc. ) for patients with chronic lymphocytic leukemia ( CLL ) or small...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.